It appears that your browser may be outdated and performance may be limited. The My Study builder is best viewed with the latest internet browsers. However, if you’d prefer to use our standard form, you can access it below.

Go to Internet Explorer Quick Quote Form

Dismiss this message

COVID-19 Saliva Sample Submission Guidelines

Updated: 20 March 2020


Prior to collecting and sending samples to Salimetrics, researchers are requested they follow the Guidance provided by the NIH, Notice Number NOT-OD-20-087, related to NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19.

Specifically: At this time, NIH encourages recipients to consult with their IRB and institutions about potential measures to protect participants and research staff. Examples of such measures are:

  • Limiting study visits to those needed for participant safety or coincident with clinical care.
  • Conducting virtual study visits
  • Arranging flexibility for required laboratory tests or imaging needed for safety monitoring to occur at local laboratories or clinics
  • Canceling large gatherings of 50 or more people
  • Limiting or suspending unnecessary travel

For our Salimetrics research community that will continue collecting saliva samples, please be advised that saliva collected from an infected participant, carries a small but viable risk of contamination from the SARS-COV-2 virus that causes COVID-19 on the vial exterior. Freezing the vials does not diminish the virus’ virulence, hence we advise that all saliva samples, once collected from the research participant, be handled while wearing disposable gloves, which should be discarded once used. We recommend this whether samples are collected by passive drool or using swabs.


Submit Samples Now
Contact: Salimetrics (USA)
View All International Distributors

Salimetrics’ COVID-19 Status – 6 April 2020 – No change to Prior Update:

Salimetrics’ Sales and Customer Service, as well as all other non-laboratory personnel, have successfully transitioned to working remote and are fully able to provide support to our customers.

Our Salimetrics Pennsylvania Manufacturing Center remains open for customer orders and shipments. All Salimetrics’ laboratory personnel are following PPE guidelines per CDC Biosafety Level 2 (BSL-2).

The Salimetrics’ SalivaLab, located in California, is open to receive samples. In accordance with State of California Executive Order N-33-20 effective March 19, 2020, our Carlsbad, California facility, including R&D and SalivaLab personnel, will remain open working on research critical to the COVID-19 response; onsite SalivaLab personnel will be able to receive samples, and in some cases, test and send data.  All Salimetrics’ laboratory personnel are following PPE guidelines per CDC Biosafety Level 2 (BSL-2).



COVID-19 Notice